Newsroom
Truveta news releases
CDC awards Truveta a real-world data contract to study COVID, maternal health, and pediatric care
BELLEVUE, Wash. – January 22, 2024 – Today, Truveta, a growing collective of 30 health systems with a shared mission of Saving Lives with Data, was awarded a contract with the U.S. Centers for Disease Control and Prevention (CDC) for privacy-preserving record linkage...
Truveta Research on increased speech delays in children during the pandemic published in JAMA Pediatrics
In a study of more than 2.4 million children under the age of 5, new research shows a significant increase in the rate of first-time speech delay diagnoses after July 2020. BELLEVUE, Wash. – December 5, 2023 – Today Truveta announced new research published in JAMA...
Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors
BELLEVUE, Wash. – December 4, 2023 – Truveta, the company with a mission of saving lives with data, welcomes its first member from the life science industry to its Board of Directors. The Truveta Board of Directors ensures the data and analytics company is operating...
Largest real-world data study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss
In the first comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data, Truveta Research found that patients with overweight or obesity taking tirzepatide were three times more likely to achieve 15%...
Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research
With more than 56.6 million clinical observations from more than 2.7 million echocardiogram reports and growing, Truveta is the market leader in real-world data for cardiovascular research. BELLEVUE, Wash. – November 8, 2023 – Today Truveta announced the availability...
More than 50 organizations choose Truveta for the most complete, timely, and clean EHR data to study safety and effectiveness, improve patient care, and train medical AI
BELLEVUE, Wash. – October 23, 2023 – Truveta announced today that it is partnering with more than 50 organizations in life sciences, healthcare, government, academic medical centers, and research institutes to study safety and effectiveness, improve patient care and...
Truveta advances security and privacy with Type 2 SOC 2 examination
Truveta has completed its Type 2 SOC 2 examination and continue to maintain ISO 27001 certifications, demonstrating the company’s relentless commitment to security, privacy, and trust. BELLEVUE, Wash.– October 11, 2023 – Truveta today announced it has completed a Type...
Partnership news: Truveta and Mathematica to advance public health and health equity with real-world data
Powerful partnership will allow researchers access to the most complete, timely, and clean health data to improve outcomes BELLEVUE, Wash. and PRINCETON, New Jersey – September 21, 2023 – Truveta, a leading EHR data and analytics company, and Mathematica, a policy...
Medical Components Inc. and Truveta partner to advance care for patients living with cancer and chronic kidney disease
Truveta Data will enable Medical Components, Inc. to study manufacturer-specific medical device data to address medical evidence gaps and improve clinical care recommendations. BELLEVUE, Wash. – September 12, 2023 – Medical Components, Inc. is partnering with Truveta...
